Sign in
CompletedNo phase

MLPR As A Diagnostic Marker For Acute Pulmonary Embolism

Key facts

Who runs it
Ain Shams University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
53 people enrolled
Started
1 Jan 2024
Ended
31 May 2025
Type of study
Observational, 2 groups
Treatments tested
  • Monocyte to Large Platelet Ratio (MLPR)
Record updated
29 May 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Only patients with the results of full blood count and white blood cell differentiation, measured before the treatment of suspected PE
  • Patients underwent CT pulmonary angiography to confirm or exclude pulmonary embolism diagnosis

Who cannot take part

  • Patient receiving any anticoagulant drug at a therapeutic dose
  • Patient on immunosuppressive drugs , Oral contraceptive pills
  • Patient with history of any myeloproliferative disorder, myelofibrosis, Glanzmann thrombasthenia, May-Hegglin anomaly, Bernard-Soulier syndrome, suspicion of disseminated intravascular coagulation
  • Patients with acute coronary syndrome, pulmonary edema
  • Patients with severe renal or hepatic disease
  • Patients with Stroke
  • Patients with malignancy
  • Patient with blood transfusion in the last 2 months

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A retrospective study to assess the utility of hematological marker (monocyte to large platelet ratio) to diagnose patients with pulmonary embolism

The 2 groups in the trial

  • Pulmonary embolism

    Group that is confirmed to have pulmonary embolism by positive CTPA finding filling defect.

    Treatment: Monocyte to Large Platelet Ratio (MLPR)

  • Non-Pulmonary embolism

    Group that have pulmonary embolism diagnosis was excluded by negative CTPA finding.

    Treatment: Monocyte to Large Platelet Ratio (MLPR)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Monocyte To Large Platelet Ratio As A Diagnostic Marker For Acute Pulmonary Embolism
Record updated
29 May 2026